L & S Advisors Inc Tandem Diabetes Care Inc Transaction History

L & S Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$86.4 - $121.75 $874,972 - $1.23 Million	-10,127 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$95.43 - $116.09 $159,368 - $193,870	1,670 Added 19.75%	10,127 $1.15 Million
Q2 2020 Aug 13, 2020	SELL	$60.05 - $98.92 $81,307 - $133,937	-1,354 Reduced 13.8%	8,457 $837,000
Q1 2020 May 13, 2020	BUY	$47.37 - $90.04 $70,865 - $134,699	1,496 Added 17.99%	9,811 $631,000
Q4 2019 Feb 13, 2020	SELL	$53.13 - $71.19 $45,957 - $61,579	-865 Reduced 9.42%	8,315 $496,000
Q3 2019 Nov 14, 2019	BUY	$57.11 - $73.3 $524,269 - $672,894	9,180 New	9,180 $541,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.97B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.